Review of 120 anal cancer patients

Colorectal Disease

Volumn 11, Issue 9, 2009, Pages 909-914

  Young, S C ^a   Solomon, M J ^b,c   Hruby, G ^c,d   Frizelle, F A ^e  

^a Premion   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d SYDNEY CANCER CENTRE   (Australia)

^e CHRISTCHURCH HOSPITAL   (New Zealand)

Author keywords

Anal cancer; Chemoradiation; Chemotherapy; Radiotherapy; Survival

Indexed keywords

FLUOROURACIL; MITOMYCIN C;

ADENOCARCINOMA; ADULT; AGED; ANUS CANCER; ARTICLE; BLEEDING; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CHRONIC DIARRHEA; COLOSTOMY; CONSTIPATION; DISEASE FREE SURVIVAL; EDEMA; FECES INCONTINENCE; FEMALE; FIBROSIS; HUMAN; HYPERPIGMENTATION; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROCTITIS; RADIATION DOSE; SALVAGE THERAPY; SQUAMOUS CELL CARCINOMA; STENOSIS; TELANGIECTASIA; TREATMENT RESPONSE; VAGINITIS;

ADULT; AGED; AGED, 80 AND OVER; ANUS NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COLOSTOMY; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PAPILLOMAVIRUS INFECTIONS; SALVAGE THERAPY; SURVIVAL ANALYSIS;

EID: 72949094957     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/j.1463-1318.2008.01723.x     Document Type: Article

References (32)

1. Hung AY, Canning CA, Patel KM et al. Radiation therapy for gastrointestinal cancer. Hematol Oncol Clin North Am 2006; 20: 287-320.
2. New Zealand Health Information Service (2002) Cancer Registrations and Deaths. Available at: http://www.nzhis. govt.nz/stats/tables/cancer2002.xls (cited 24 February 2007)
3. Australian Institute of Health and Welfare (2007) Interactive Cancer Data. Available at: http://www.aihw.gov.au/cognos/cgi-bin/ppdscgi.exe?DC=Q&E=/Cancer/can cerageratesv7 (cited 24 February 2007).
4. Nigro ND, Vaitkevicius VK, Considine B Jr. Combined therapy for cancer of the anal canal: a preliminary report. Dis Colon Rectum 1974; 17: 354-6.
5. Buroker TR, Nigro N, Bradley G et al. Combined therapy for cancer of the anal canal: a follow-up report. Dis Colon Rectum 1977; 20: 677-8.
6. Cummings B, Brierley J. (2004 4th edition) Anal cancer. In: Principles and Practice of Radiation Oncolog (eds Perez CA, Brady LW, Halperin EC, Schmidt-Ullrich RK), p. 1630. Lippincott Williams and Wilkins, Philadelphia.
7. Rich TA, Ajani JA, Morrison WH et al. Chemoradiation therapy for anal cancer: radiation plus continuous infusion of 5-fluorouracil with or without cisplatin. Radiother Oncol 1993; 27: 209-15.
8. Gerard JP, Ayzac L, Hun D et al. Treatment of anal canal carcinoma with high dose radiation therapy and concomitant fluorouracil-cisplatinum. Long-term results in 95 patients. Radiother Oncol 1998; 46: 249-56.
9. Grabenbauer GG, Kessler H, Matzel KE et al. Tumor site predicts outcome after radiochemotherapy in squamous-cell carcinoma of the anal region: long-term results of 101 patients. Dis Colon Rectum 2005; 48: 1742-51.
10. Wong S, Gibbs P, Chao M et al. Carcinoma of the anal canal: a local experience and review of the literature. ANZ J Surg 2004; 74: 541-6.
11. Dwyer MK, Gebski VJ, Jayamohan J. The bottom line: outcomes after conservation treatment in anal cancer. Aus-tralas Radiol 2006; 50: 46-51.
12. Peiffert D, Bey P, Pernot M et al. Conservative treatment by irradiation of epidermoid cancers of the anal canal: prognos-tic factors of tumoral control and complications. Int J Radiat Oncol Biol Phys 1997; 37: 313-24.
13. Nilsson PJ, Svensson C, Goldman S et al. Epidermoid anal cancer: a review of a population-based series of 308 consecutive patients treated according to prospective proto-cols. Int J Radiat Oncol Biol Phys 2005; 61: 92-102.
14. Sato H, Koh PK, Bartolo D.C. Management of anal canal cancer. Dis Colon Rectum 2005; 48: 1301-15.
15. Fuchshuber PR, Rodriguez-Bigas M, Weber T et al. Anal canal and perianal epidermoid cancers. J Am Coll Surg 1997; 185: 494-505.
16. Frisch M, Olsen JH, Melbye M. Malignancies that occur before and after anal cancer: clues to their etiology. Am J Epidemiol 1994; 140: 12-9.
17. Frisch M, Glimelius B, van den Brule AJ et al. Sexually transmitted infection as a cause of anal cancer. N Engl J Med 1997; 337: 1350-8.
18. Bjorge T, Engeland A, Luostarinen T et al. Human papil-lomavirus infection as a risk factor for anal and perianal skin cancer in a prospective study. Br J Cancer 2002; 87: 61-4.
19. Klotz RG Jr, Pamukcoglu T, Souilliard D.H. Transitional cloacogenic carcinoma of the anal canal. Clinicopathologic study of three hundred seventy-three cases. Cancer. 1967; 20: 1727-45.
20. Greenall MJ, Quan SH, Urmacher C. Treatment of epider-moid carcinoma of the anal canal. Surg Gynecol Obstet 1985; 161: 509-17.
21. Beahrs OH, Wilson S.M. Carcinoma of the anus. Ann Surg 1976; 184: 422-8.
22. Boman BM, Moertel CG, O'Connell MJ et al. Carcinoma of the anal canal. A clinical and pathologic study of 188 cases. Cancer 1984; 54: 114-25.
23. Ajani JA, Winter KA, Gunderson LL et al. Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial. JAMA 2008; 299: 1914-21.
24. Ryan DP, Compton CC, Mayer R.J. Carcinoma of the anal canal. N Engl J Med 2000; 342: 792-800.
25. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research. Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. Lancet. 1996; 348: 1049-54.
26. Flam M, John M, Pajak TF et al. Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treat-ment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. J Clin Oncol 1996; 14: 2527-39.
27. Bartelink H, Roelofsen F, Eschwege F et al. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol 1997; 15: 2040-9.
28. Broens P, Van Limbergen E, Penninckx F et al. Clinical and manometric effects of combined external beam irradiation and brachytherapy for anal cancer. Int J Colorectal Dis 1998; 13: 68-72.
29. Tanum G, Tveit K, Karlsen KO et al. Chemotherapy and radiation therapy for anal carcinoma. Survival and late morbidity. Cancer 1991; 67: 2462-6.
30. Giebel GD, Lefering R, Troidl H et al. Prevalence of fecal incontinence: what can be expected? Int J Colorectal Dis 1998; 13: 73-7.
31. Kalantar JS, Howell S, Talley N.J. Prevalence of faecal incontinence and associated risk factors; an underdiagnosed problem in the Australian community? Med J Aust 2002; 176: 54-7.
32. Karandikar SS, Borley A, Crosby T et al. A five-year audit of anal cancer in WalesColorectal Dis 2006; 8: 266-72.